(Hypertension. 1995;25:752-757.)
© 1995 American Heart Association, Inc.
Articles |
From the Department of Pharmacology, New York Medical College, Valhalla.
| Abstract |
|---|
|
|
|---|
Key Words: hypertension, arterial muscle, smooth, vascular nitric oxide protein kinase C calcium vasoconstriction
| Introduction |
|---|
|
|
|---|
Inhibitors of nitric oxide (NO) synthesis were reported to promote tension development in aortic smooth muscle from SHR5 and rats with aortic coarctationinduced hypertension.4 The aortic constrictor responses to inhibitors of NO synthesis in these hypertensive rats may result from a heightening of the mechanisms responsible for implementation of the high basal tone. In this respect, NO is known to serve as a counterregulatory influence to mechanisms of vascular contraction6 7 by means of cyclic guanosine monophosphate (cGMP)mediated mechanisms that reduce intracellular calcium or interfere with its increase during hormonal stimulation.8
The present study was undertaken to investigate the regulatory influence of NO on the basal tone of rings of thoracic aortae taken from sham-operated normotensive rats and rats with aortic coarctationinduced hypertension of 7 to 14 days' duration. First, we examined the effects of endothelium removal and an inhibitor of NO synthesis on the expression of calcium- and PKC-dependent basal tone in aortic rings from normotensive and hypertensive rats. Second, we compared aortic rings from normotensive and hypertensive rats, with and without endothelium, in terms of the effects of sodium nitroprusside (SNP), acetylcholine, and L-arginine on basal tone.
| Methods |
|---|
|
|
|---|
Animals
Experiments were conducted on male Sprague-Dawley rats
(300 to 350 g, Charles River) with aortic coarctationinduced
hypertension of 7 to 14 days' duration and on sham-operated,
normotensive controls (n=30 for both groups). The rats were prepared
according to surgical procedures described in detail
elsewhere4 and approved by the Institutional Animal Care
and Use Committee of New York Medical College.
Measurement of Isometric Tension
On the day of the experiment, rats were anesthetized with sodium
pentobarbital (60 mg/kg IP), the carotid artery was cannulated with
polyethylene tubing (PE 50), and arterial blood pressure was measured.
Mean arterial pressure was elevated in rats 7 to 14 days after aortic
coarctation (168±6 versus 105±5 mm Hg for controls,
P<.05). After blood pressure measurement, the descending
thoracic aortas were removed and prepared as ring segments according to
previously published methods.4 In some experiments, the
lumenal surfaces of aortic rings were rubbed to remove the endothelium.
Each aortic ring was placed in a tissue bath filled with Krebs'
bicarbonate buffer (37°C), bubbled with 95%
O2/5% CO2, stretched to 2.0 g of
isometric tension, and allowed to equilibrate for 60 to 90 minutes with
changes in buffer at 15-minute intervals. In preliminary experiments,
we found that 2.0 g of tension was optimal for expression of
contractile responses induced by KCl (120 mmol/L) in aortic rings from
both groups. In some experiments, L-NAME (3x10-4 mol/L)
was added to the tissue bath from the outset of the equilibration
period to inhibit NO synthesis.9 When isometric tension
was stable, the experiments were performed.
In one series of experiments, we assessed the effects of calcium-free Krebs' buffer on the basal tone of unrubbed and rubbed aortic rings from normotensive and hypertensive rats, with and without L-NAME added to the tissue bath at the onset of equilibration. In a second series of experiments, we examined the effects of staurosporine (10-8 mol/L) or calphostin C (10-6 mol/L), potent inhibitors of PKC,10 11 on basal tone of unrubbed and rubbed aortic rings from normotensive controls and hypertensive rats. In aortic rings from normotensive rats, these concentrations of staurosporine and calphostin C were sufficient to block contractile responses to a maximally effective concentration of TPA (10-6 mol/L). In a third series of experiments, we compared the effects of cumulative addition of SNP (an NO-generating agent12 ), acetylcholine (which stimulates NO synthesis in endothelial cells13 ), or L-arginine (the substrate for NO synthesis14 ) on basal tone of unrubbed and rubbed aortic rings from these normotensive and hypertensive rats. The effects of D-arginine, the inactive enantiomer of L-arginine,14 or L-lysine, a basic amino acid subject to transcellular transport mechanisms similar to those of L-arginine,15 on basal tone of unrubbed and rubbed aortic rings from hypertensive rats were assessed in similar experiments. At the end of experiments examining the effects of L-arginine, D-arginine, and L-lysine, SNP (5x10-6 mol/L) was administered to determine the maximal SNP-inhibitable tone. After the experiments were completed, aortic rings were allowed to dry for at least 24 hours and then weighed. Results are expressed as the change in isometric tension induced by calcium-free buffer or experimental drugs, normalized by the dry weight of the vascular rings.
Measurement of cGMP Levels in Aortic Rings From Normotensive and
Hypertensive Rats
Complementary experiments were performed to compare the cGMP
content of aortic rings from hypertensive and normotensive rats. In
brief, aortic rings (two per condition) were equilibrated in Krebs'
bicarbonate buffer containing IBMX (0.5 mmol/L) for 1 hour in a shaking
water bath at 37°C. At the midpoint of the equilibration period, MB
(10-5 mol/L), an inhibitor of soluble guanylate
cyclase,12 was added to the appropriate tubes. After
equilibration, the buffer was replaced with fresh buffer containing
IBMX and the following agents: vehicle (no additions), acetylcholine
(10-6 mol/L) alone, acetylcholine (10-6
mol/L) and MB (10-5 mol/L), L-arginine
(10-3 mol/L) alone, L-arginine
(10-3 mol/L) and MB (10-5 mol/L), and SNP
(5x10-6 mol/L). The rings were then incubated for 5
minutes, after which time they were snap-frozen in liquid nitrogen and
stored at -70°C until assay for cGMP according to published
methods.4 16
Measurement of PKC Activity in Homogenates of Aortas From
Normotensive and Hypertensive Rats
We measured PKC activity in homogenates of aortic tissue from
sham-operated normotensive rats and hypertensive rats 7 to 14 days
after aortic coarctation according to published methods,17
with minor modifications. The descending thoracic aortae of rats were
excised, cleared of excess blood and periadventitial tissue in ice-cold
NaCl solution (0.15 mol/L), snap-frozen in liquid nitrogen, and stored
at -70°C until assayed. At the time of assay, aortas (one per assay)
were homogenized (Polytron, Brinkman) in TRIS buffer (20 mmol/L, pH
7.5) with EDTA and EGTA (0.5 mmol/L each); leupeptin and aprotinin
(0.025 mg/ml each); ß-mercaptoethanol (10 mmol/L); and Triton X-100
(0.5%). Homogenization and all subsequent preparatory steps were
carried out at 4°C. Homogenates were incubated for 30 minutes and
centrifuged at 10 000g for 15 minutes. Supernatants were
then subjected to anion exchange chromatography (DEAE-Sephacel) to
partially purify the samples, and column eluates were assayed for total
PKC activity with a commercially available kit (GIBCO BRL). In brief, a
specific substrate peptide, N-acetylated myelin basic
protein fragment 4-14 (0.05 mmol/L), was combined with column eluate
(0.5 to 1.5 µg protein) in TRIS buffer (20 mmol/L, pH 7.5) containing
MgCl2 (20 mmol/L), CaCl2 (1 mmol/L), adenosine
triphosphate (ATP) (0.02 mmol/L), and
-[32P]ATP (0.625
µCi per assay tube; specific activity, 3000 Ci/mmol; Du Pont NEN) in
the presence of lipid reagent (0.01 mmol/L phorbol
12-myristate-13-acetate, 0.28 mg/mL phosphatidyl serine, and Triton
X-100 mixed micelles) or of pseudosubstrate peptide PKC(19-36) and
incubated for 5 minutes at 30°C. Phosphorylation of the substrate
peptide was assessed by scintillation spectrophotometry of aliquots of
incubate that had been placed on phosphocellulose discs and washed with
phosphoric acid and water. PKC specific activity was defined as the
difference between activity in the presence of lipid reagent versus
that in the presence of pseudosubstrate peptide, and was expressed as
picomoles of incorporated phosphate per minute per milligram protein
(Biorad).
Statistical Analysis
Results are expressed as mean±SEM. Unless otherwise specified,
n in figures, legends, and text denotes the number of vascular rings
taken from four or more rats. Data were analyzed by paired or unpaired
Student's t test or by ANOVA, as appropriate (see figure
legends for specific test used). If differences were noted by ANOVA,
the Newman-Keuls modified t test was used to make specific
comparisons. PKC activity data were subjected to logarithmic
transformation before application of Student's t test. The
null hypothesis was rejected when the P value was <.05.
| Results |
|---|
|
|
|---|
|
Staurosporine (10-8 mol/L) and calphostin C also induced relaxant responses in unrubbed and rubbed aortic rings from hypertensive rats (Fig 2), the relaxations being greater in rubbed than in unrubbed rings. These agents had no effect on tension of rings from normotensive controls. The magnitudes of the responses to staurosporine and calphostin C were virtually identical to those seen with calcium-free buffer. Of note, total PKC activity was increased approximately 3.5-fold in aortic homogenates from hypertensive rats compared with those from normotensive controls (2124±785 versus 608±73 pmol · min-1 · mg protein-1; n=9 and n=5, respectively; P<.05).
|
Fig 3 shows the effects of SNP, acetylcholine, and L-arginine on basal tone of aortic rings from normotensive and hypertensive rats. No effect on tension of aortic rings from normotensive, sham-operated rats was elicited by SNP (up to 10-5 mol/L), acetylcholine, or L-arginine. SNP caused relaxation of both unrubbed and rubbed aortic rings from hypertensive rats. At the highest concentrations of SNP, the relaxant response was greater in rubbed than in unrubbed rings. Acetylcholine caused relaxation of unrubbed aortic rings from hypertensive rats but had no effect on tension of rubbed rings. L-Arginine caused relaxation of both unrubbed and rubbed rings from hypertensive rats. Although responses to L-arginine were similar in unrubbed and rubbed rings when expressed as grams of tension per milligram of tissue, the maximal effect of L-arginine was greater in unrubbed rings than in rubbed rings when expressed as a percentage of SNP-inhibitable tone (61±14% versus 28±8%; n=7 and n=5, respectively; P<.05). Neither D-arginine nor L-lysine (10-5, 10-4, and 10-3 mol/L) had relaxant effects on unrubbed aortic rings from hypertensive rats 7 to 14 days after aortic coarctation (-0.01±0.03, -0.05±0.04, and -0.05±0.06 g tension/mg tissue for D-arginine [n=7] and -0.04±0.03, -0.02±0.06, and 0.22±0.14 g tension/mg tissue for L-lysine [n=6], respectively). SNP-inhibitable tone in aortic rings exposed to D-arginine and L-lysine was 0.77±0.23 and 0.68±0.14 g tension/mg tissue, respectively.
|
Because the vasodilatory effects of NO are mediated by increases of cGMP in vascular smooth muscle,11 we measured cGMP content of aortic rings from normotensive and hypertensive rats in the absence and presence of acetylcholine, L-arginine, or SNP. The Table illustrates cGMP levels in unrubbed aortic rings from these rats. Although basal cGMP levels and the stimulatory effects of acetylcholine and SNP on cGMP were similar in both groups, L-arginine increased cGMP in aortic rings from hypertensive rats 7 to 14 days after aortic coarctation but not in those from normotensive controls. Prior exposure to MB blocked the increases of cGMP caused by acetylcholine in both groups and by L-arginine in aortic rings from hypertensive rats. Of further interest, L-arginine (10-3 mol/L) also induced a small but significant increase of cGMP in rubbed aortic rings from hypertensive rats (basal level, 3.5±0.6 pmol/mg protein; with L-arginine, 7.7±1.4 pmol/mg protein [n=5; P<.05]). In rubbed aortic rings from both groups, acetylcholine had no effect on cGMP levels, and SNP induced similar increases in cGMP in aortic rings from hypertensive and normotensive rats (244±59 versus 193±50 pmol/mg protein; n=10 and n=9, respectively).
|
| Discussion |
|---|
|
|
|---|
-adrenoceptor agonists are accentuated compared with normotensive
controls. Also, higher basal [Ca2+]i has been
observed in unstimulated vascular smooth muscle cells of
SHR21 and rats with aortic coarctationinduced
hypertension.22 Aberrant calcium metabolism in vascular
smooth muscle of hypertensive rats may be linked to altered
phospholipase Cmediated inositol phosphate production,23
altered calcium channel activity,24 altered release of
calcium from intracellular stores,25 or altered removal of
calcium from the cytosol.26 The mechanisms responsible for
the development of calcium-dependent tone in the aortas of hypertensive
rats are not clear at this point. The high resting tone in aortic rings from hypertensive rats 7 to 14 days after aortic coarctation may be linked to activation of PKC. That staurosporine and calphostin C caused relaxation of basally equilibrated aortic rings from hypertensive rats implies that development of active tone in these aortic rings is dependent on a mechanism of vascular contraction mediated by PKC. In support of this notion, we found that total PKC activity in aortic tissue from hypertensive rats was increased more than threefold over that in tissue from normotensive controls. Functional studies in isolated tissues strongly suggest that PKC-mediated mechanisms of vascular contraction are altered in hypertension and may be important contributing factors to increased vascular resistance. Enhanced sensitivity to phorbol esterinduced PKC activation and the associated contractions have been observed in aortic rings from SHR27 and from rats with aortic coarctationinduced hypertension.28 Also, a PKC inhibitor attenuated contractile responses to norepinephrine and angiotensin II to a greater degree in aortic rings from SHR than in those from normotensive controls,29 suggesting that contractile responses to these agonists have a greater dependence on PKC in SHR. Although the mechanisms by which PKC mediates vascular contraction are not fully elucidated, current evidence suggests that downstream effects of PKC activation to enhance calcium mobilization30 and/or increase the sensitivity of contractile elements to calcium31 are important factors. Hence, it is plausible that the calcium-dependent tone in aortic rings from rats with aortic coarctationinduced hypertension is a consequence of increased PKC activity. Because PKC may participate in the mechanisms underlying myogenic responses to stretch,32 one may also consider the possibility that under the conditions of our study, the development of calcium- and PKC-dependent tone by the aortic smooth muscle of hypertensive rats is reflective of an exaggerated myogenic response to stretch of the aortic rings of these animals ex vivo.
Both calcium-dependent tone and staurosporine-inhibitable tone were greater in endothelium-denuded aortic rings than in endothelium-intact aortic rings from hypertensive rats. This finding suggests that an endothelium-derived factor inhibits the development of tone in aortic rings from hypertensive rats. Endothelium-dependent inhibition of the contractile actions of a variety of agonists is well documented. In our studies the endothelial factor appeared to be NO, because treatment of intact aortic rings from hypertensive rats with L-NAME to inhibit NO synthesis increased calcium-dependent tone. Therefore, it may be concluded that endogenous NO acts to suppress the development of calcium- and PKC-dependent tone in aortic rings from rats with aortic coarctationinduced hypertension. In strong support of this notion, SNP, acetylcholine, and L-arginine, but not D-arginine or L-lysine, reversed, in concentration-dependent fashion, the calcium- and PKC-dependent tone in aortic rings from these hypertensive rats. That the relaxant effects of SNP, acetylcholine, and L-arginine are due to augmentation of NO levels in aortic rings from hypertensive rats is corroborated by our observation that the relaxant effects of each of these agents were paralleled by increases in cGMP levels: SNP induced relaxation and increased cGMP in endothelium-intact and endothelium-denuded rings; acetylcholine induced relaxation and increased cGMP only in endothelium-intact rings; and L-arginine induced relaxation and increased cGMP in both endothelium-intact and endothelium-denuded rings.
L-Arginineinduced relaxation and increases of cGMP in aortic rings from hypertensive rats were blunted but not eliminated by rubbing to remove the vascular endothelium. This suggests that the inhibitory effect of L-arginine on isometric tension development in these aortic rings has both endothelium-dependent and endothelium-independent components. This finding parallels our previous report that contraction of aortic rings induced by inhibition of NO also has both endothelium-dependent and endothelium-independent components.4 Although we cannot unequivocally rule out the possibility that residual functional endothelium could account for the effects of L-arginine, this is unlikely because we have demonstrated that rubbing completely eliminates acetylcholine-induced relaxation4 and cGMP generation in aortic rings from rats with aortic coarctationinduced hypertension. The synthesis of NO is catalyzed by a constitutive NO synthase, found in endothelial cells,33 and, in some pathological conditions, by inducible NO synthase found in vascular smooth muscle,34 endothelial cells,35 and activated macrophages36 and leukocytes.37 Thus, our data support the notion that inhibition of NO synthesis by L-NAME and augmentation of substrate availability to NO synthase with L-arginine at sites other than the vascular endothelium may account for the vasoactivity of these agents in endothelium-denuded aortic rings.
Our findings and conclusions conform with the hypothetical scheme illustrated in Fig 4. Aortic rings from hypertensive rats feature a high level of constrictor tone in the absence of exogenous vasoconstrictors. This tone is calcium-dependent and also appears to be related to a PKC-mediated mechanism of vascular contraction. Both exogenous and endogenous NO suppress the development of this tone in aortic rings from hypertensive rats. The actions of NO to antagonize the development of tone may be functional in nature or may, instead, involve more direct interactions with the constrictor mechanisms that are operational in the vasculature of hypertensive rats. Our findings raise the possibilities that a calcium-dependent, PKC-mediated mechanism of vascular contraction fosters elevation of vascular resistance in these rats with aortic coarctationinduced hypertension and that endogenous NO serves as a counterregulatory influence to this vasoconstrictor mechanism.
|
| Acknowledgments |
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
2.
Sada T, Koike H, Nishino H, Oizumi K. Chronic inhibition of
angiotensin converting enzyme decreases Ca2+-dependent tone
of aorta in hypertensive rats. Hypertension. 1989;13:582-588.
3. Sunano S, Osugi S, Yamamoto K, Shimamura K. Influence of the endothelium on the elevation of basal tension in aortae from various strains of spontaneously hypertensive rats. J Cardiovasc Pharmacol. 1991;17(suppl 3):S137-S140.
4. Pucci ML, Miller KB, Dick LB, Guan H, Lin L, Nasjletti A. Vascular responsiveness to nitric oxide synthesis inhibition in hypertensive rats. Hypertension. 1994;23(pt 1):744-751.
5. Dyre SM, Taylor DA, Bexis S, Hime NJ, Frewin DB, Head RJ. Identification of a nonendothelial cell thromboxane-like constrictor response and its interaction with the renin-angiotensin system in the aorta of spontaneously hypertensive rats. J Vasc Res. 1994;31:52-60. [Medline] [Order article via Infotrieve]
6. Topouzis S, Schott C, Stoclet J-C. Participation of endothelium-derived relaxing factor and the role of cyclic GMP in inhibitory effects of endothelium on contractile responses elicited by alpha-adrenoceptor agonists in rat aorta. J Cardiovasc Pharmacol. 1991;18:670-678. [Medline] [Order article via Infotrieve]
7. Gruetter CA, Ryan ET, Lemke SM, Bailly DA, Fox MK, Schoepp DD. Endothelium-dependent modulation of angiotensin II-induced contraction in blood vessels. Eur J Pharmacol. 1988;146:85-95. [Medline] [Order article via Infotrieve]
8. Lincoln TM, Cornwell TL. Towards an understanding of the mechanism of action of cyclic AMP and cyclic GMP in smooth muscle relaxation. Blood Vessels. 1991;28:129-137. [Medline] [Order article via Infotrieve]
9. Rees DD, Palmer RMJ, Schulz R, Hodson HF, Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol. 1990;101:746-752. [Medline] [Order article via Infotrieve]
10. Tamaoki T, Nomoto H, Takashi I, Kato Y, Morimoto M, Tomita F. Staurosporine, a potent inhibitor of phospholipid/Ca2+-dependent protein kinase C. Biochem Biophys Res Comm. 1986;135:397-402. [Medline] [Order article via Infotrieve]
11.
Shimamoto Y, Shimamoto H, Kwan CY, Daniel EE. Differential
effects of putative protein kinase C inhibitors on contraction of rat
aortic smooth muscle. Am J Physiol. 1993;264:H1300-H1306.
12.
Gruetter CA, Gruetter DY, Lyon JE, Kadowitz PJ, Ignarro LJ.
Relationship between cyclic guanosine 3':5'-monophosphate
formation and
relaxation of coronary arterial smooth muscle by glyceryl trinitrate,
nitroprusside, nitrite and nitric oxide: effects of methylene
blue and methemoglobin. J Pharmacol Exp Ther. 1981;219:181-186.
13. Rees DD, Palmer RMJ, Hodson HF, Moncada S. A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br J Pharmacol. 1989;96:418-424. [Medline] [Order article via Infotrieve]
14. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 1988;333:664-666. [Medline] [Order article via Infotrieve]
15.
Greene B, Pacitti AJ, Souba WW. Characterization of
L-arginine transport by pulmonary artery endothelial
cells. Am J Physiol. 1993;264:L351-L356.
16. Brooker G, Harper JF, Terasaki WL, Moylan RD. Radioimmunoassay of cyclic AMP and cyclic GMP. In: Brooker G, Greengard P, Robison GA, eds. Advances in Cyclic Nucleotide Research. New York, NY: Raven Press Publishers; 1979;10:1-33.
17. Yasuda I, Kishimoto A, Tanaka S, Tominaga M, Sakurai A, Nishizuka Y. A synthetic peptide substrate for selective assay of protein kinase C. Biochem Biophys Res Commun. 1990;166:1220-1227. [Medline] [Order article via Infotrieve]
18. Morgan KG, Papageorgiou P, Jiang MJ. Pathophysiologic role of calcium in the development of vascular smooth muscle tone. Am J Cardiol. 1989;64:35F-40F. [Medline] [Order article via Infotrieve]
19.
Bell DR, Bohr DF. Endothelium in functional aortic changes of
coarctation hypertension. Am J Physiol. 1991;260:H1187-H1193.
20.
Papageorgiou P, Morgan KG. Increased Ca2+
signaling after alpha-adrenoceptor activation in vascular hypertrophy.
Circ Res. 1991;68:1080-1084.
21. Losse H, Zidek W, Vetter H. Intracellular sodium and calcium in vascular smooth muscle of spontaneously hypertensive rats. J Cardiovasc Pharmacol. 1984;6(suppl 1):S32-S34.
22.
Papageorgiou P, Morgan KG. Intracellular free
Ca2+
is elevated in hypertrophic aortic muscle from hypertensive rats.
Am J Physiol. 1991;260:H507-H515.
23.
Uehara Y, Ishi M, Ishimitsu T, Sugimoto T. Enhanced
phospholipase C activity in the vascular wall of spontaneously
hypertensive rats. Hypertension. 1988;11:28-33.
24. Sharma RV, Bhalla RC. Calcium and abnormal reactivity of vascular smooth muscle in hypertension. Cell Calcium. 1988;9:267-274. [Medline] [Order article via Infotrieve]
25. Aqel MB, Sharma RV, Bhalla RC. Increased norepinephrine-sensitive intracellular Ca2+ pool in the caudal artery of spontaneously hypertensive rats. J Hypertens. 1987;5:249-253. [Medline] [Order article via Infotrieve]
26. Bohr DF, Webb RC. Vascular smooth muscle membrane in hypertension. Annu Rev Pharmacol Toxicol. 1988;28:389-409. [Medline] [Order article via Infotrieve]
27. Bruschi G, Bruschi ME, Capelli P, Regolisti G, Borghetti A. Increased sensitivity to protein kinase C activation in aortas of spontaneously hypertensive rats. J Hypertens. 1988;6(suppl 4):S248-S251.
28. Turla MB, Park SM, Webb RC. Vascular responsiveness to phorbol esters in coarctation-hypertensive rats. J Hypertens. 1990;8:191-196. [Medline] [Order article via Infotrieve]
29. Shibata R, Morita S, Nagai K, Miyata S, Iwasaki T. Effects of H-7 (protein kinase inhibitor) and phorbol ester on aortic strips from spontaneously hypertensive rats. Eur J Pharmacol. 1990;175:261-271. [Medline] [Order article via Infotrieve]
30.
Rembold CM, Murphy RA. [Ca2+]-dependent
myosin
phosphorylation in phorbol diester stimulated smooth muscle
contraction. Am J Physiol. 1988;255:C719-C723.
31.
Collins EM, Walsh MP, Morgan KG. Contraction of single
vascular smooth muscle cells by phenylephrine at constant
[Ca2+]i. Am J Physiol. 1992;262:H754-H762.
32.
Pawlowski J, Morgan KG. Mechanisms of intrinsic tone in ferret
vascular smooth muscle. J Physiol (Lond). 1992;448:121-132.
33. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev. 1991;43:109-142. [Medline] [Order article via Infotrieve]
34. Busse R, Mulsch A. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett. 1990;275:87-90. [Medline] [Order article via Infotrieve]
35. Gross SS, Jaffe EA, Levi R, Kilbourn RG. Cytokine-activated endothelial cells express an isotype of nitric oxide synthase which is tetrahydrobiopterin-dependent, calmodulin-independent and inhibited by arginine analogs with a rank order of potency characteristic of activated macrophages. Biochem Biophys Res Commun. 1991;178:823-829. [Medline] [Order article via Infotrieve]
36.
Stuehr DJ, Gross SS, Sakuma I, Levi R, Nathan CF. Activated
murine macrophages secrete a metabolite of arginine with the
bioactivity of endothelium-derived relaxing factor and
the chemical reactivity of nitric oxide. J Exp Med. 1989;169:1011-1020.
37.
Yui Y, Hattori R, Kosuga K, Eizawa H, Hiki K, Ohkawa S,
Ohnishi K, Terao S, Kawai C. Calmodulin-independent nitric oxide
synthase from rat polymorphonuclear neutrophils. J Biol
Chem. 1991;266:3369-3371.
This article has been cited by other articles:
![]() |
J.-S. Wang, H. Singh, F. Zhang, T. Ishizuka, H. Deng, R. Kemp, M. S. Wolin, T. H. Hintze, N. G. Abraham, A. Nasjletti, et al. Endothelial Dysfunction and Hypertension in Rats Transduced With CYP4A2 Adenovirus Circ. Res., April 14, 2006; 98(7): 962 - 969. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Ungvari, A. Csiszar, P. M. Kaminski, M. S. Wolin, and A. Koller Chronic High Pressure-Induced Arterial Oxidative Stress: Involvement of Protein Kinase C-Dependent NAD(P)H Oxidase and Local Renin-Angiotensin System Am. J. Pathol., July 1, 2004; 165(1): 219 - 226. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Wehrwein, C. A. Northcott, R. D. Loberg, and S. W. Watts Rho/Rho Kinase and Phosphoinositide 3-Kinase Are Parallel Pathways in the Development of Spontaneous Arterial Tone in Deoxycorticosterone Acetate-Salt Hypertension J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 1011 - 1019. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Northcott, M. N. Poy, S. M. Najjar, and S. W. Watts Phosphoinositide 3-Kinase Mediates Enhanced Spontaneous and Agonist-Induced Contraction in Aorta of Deoxycorticosterone Acetate-Salt Hypertensive Rats Circ. Res., August 23, 2002; 91(4): 360 - 369. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rapacon-Baker, F. Zhang, M. L. Pucci, H. Guan, and A. Nasjletti Expression of myogenic constrictor tone in the aorta of hypertensive rats Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2001; 280(4): R968 - R975. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yamada, S. N. Iyer, M. C. Chappell, D. Ganten, and C. M. Ferrario Converting Enzyme Determines Plasma Clearance of Angiotensin-(1–7) Hypertension, September 1, 1998; 32(3): 496 - 502. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Macica, Y. Yang, K. Lerea, S. C. Hebert, and W. Wang Role of the NH2 terminus of the cloned renal K+ channel, ROMK1, in arachidonic acid-mediated inhibition Am J Physiol Renal Physiol, January 1, 1998; 274(1): F175 - F181. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dellipizzi, M. L. Pucci, A. Y. Mosny, K. Deseyn, and A. Nasjletti Contribution of Constrictor Prostanoids to the Calcium-Dependent Basal Tone in the Aorta from Rats with Aortic Coarctation-Induced Hypertension: Relationship to Nitric Oxide J. Pharmacol. Exp. Ther., October 1, 1997; 283(1): 75 - 81. [Abstract] [Full Text] |
||||
![]() |
S. d. F. Cortes, V. S. Lemos, and J.-C. Stoclet Alterations in Calcium Stores in Aortic Myocytes From Spontaneously Hypertensive Rats Hypertension, June 1, 1997; 29(6): 1322 - 1328. [Abstract] [Full Text] |
||||
![]() |
H. Guan, V. Cachofeiro, M. L. Pucci, P. M. Kaminski, M. S. Wolin, and A. Nasjletti Nitric Oxide and the Depressor Response to Angiotensin Blockade in Hypertension Hypertension, January 1, 1996; 27(1): 19 - 24. [Abstract] [Full Text] |
||||
![]() |
H. M. Wright and K. U. Malik Prostacyclin Synthesis Elicited by Endothelin-1 in Rat Aorta Is Mediated by an ETA Receptor via Influx of Calcium and Is Independent of Protein Kinase C Hypertension, December 1, 1995; 26(6): 1035 - 1040. [Abstract] [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |